Background: Early identification of patients with high mortality risk is critical for optimizing the clinical management of drug-induced liver injury(DILI). We aimed to develop and validate a new prognostic model to p...Background: Early identification of patients with high mortality risk is critical for optimizing the clinical management of drug-induced liver injury(DILI). We aimed to develop and validate a new prognostic model to predict death within 6 months in DILI patients. Methods: This multicenter study retrospectively reviewed the medical records of DILI patients admitted to three hospitals. A DILI mortality predictive score was developed using multivariate logistic regression and was validated with area under the receiver operating characteristic curve(AUC). A high-mortality-risk subgroup was identified according to the score. Results: Three independent DILI cohorts, including one derivation cohort( n = 741) and two validation cohorts( n = 650, n = 617) were recruited. The DILI mortality predictive(DMP) score was calculated using parameters at disease onset as follows: 1.913 × international normalized ratio + 0.060 × total bilirubin(mg/d L) + 0.439 × aspartate aminotransferase/alanine aminotransferase – 1.579 × albumin(g/d L) –0.006 × platelet count(109/L) + 9.662. The predictive performance for 6-month mortality of DMP score was desirable, with an AUC of 0.941(95% CI: 0.922-0.957), 0.931(0.908-0.949) and 0.960(0.942-0.974) in the derivation, validation cohorts 1 and 2, respectively. DILI patients with a DMP score ≥ 8.5 were stratified into high-risk group, whose mortality rates were 23-, 36-, and 45-fold higher than those of other patients in the three cohorts. Conclusions: The novel model based on common laboratory findings can accurately predict mortality within 6 months in DILI patients, which should serve as an effective guidance for management of DILI in clinical practice.展开更多
The fame of regeneration has been attributed to the liver ever since the era of Greek mythology,in which Prometheus’liver could grow back overnight against the daily predation of Zeus’eagle.Hepatectomy is the very b...The fame of regeneration has been attributed to the liver ever since the era of Greek mythology,in which Prometheus’liver could grow back overnight against the daily predation of Zeus’eagle.Hepatectomy is the very basis of liver surgery including liver transplantation,and post-hepatectomy liver regeneration remains the center of interest for both clinicians and scientists.Novel tools for structural and functional assessment of liver regeneration have been constantly developed and validated,laying the groundwork for clinical management and scientific analysis(1).展开更多
An innovative K+vacant ternary perovskite fluoride(K_(0.89)Ni_(0.02)Co_(0.03)Mn_(0.95)F_(3.0),KNCMF-3#)anode was designed for advanced Li-ion supercapattery(i.e.,Li-ion capacitors/batteries,LIC/Bs).Owing to the conver...An innovative K+vacant ternary perovskite fluoride(K_(0.89)Ni_(0.02)Co_(0.03)Mn_(0.95)F_(3.0),KNCMF-3#)anode was designed for advanced Li-ion supercapattery(i.e.,Li-ion capacitors/batteries,LIC/Bs).Owing to the conversion/insertion dual mechanisms and fast pseudocapacitive con-trol dynamics,the KNCMF-3#electrode exhibits superior electrochemical performance,especially the excellent cycle performance(467%(229 mAh·g^(-1))/1000 cycles/2 A·g^(-1)).Moreover,the hybrid KNCMF-3#/reduced gra-phene oxide(rGO)electrode can further increase the electrochemical performance(217-97 mAh·g^(-1)/0.1-3.2 A·g^(-1),150%(197 mAh·g^(-1))/1000 cycles/2 A·g^(-1)).Also,a novel capacitor/battery cathode,activated carbon(AC)+LiFePO_(4)+graphene(AC+LFP+G),exhibits impres-sive performance(128-82 mAh·g^(-1)/0.1-3.2 A·g^(-1),84%/1000 cycles/2 A·g^(-1)).By the synergistic optimization of anode and cathode,the Li-ion supercapattery KNCMF-3#@rGO//AC+LFP+G demonstrates remarkable per-formance,for example,111.9-23.8 Wh·kg^(-1)/0.4-8.0 kW·kg^(-1)/82%/2000 cycles/5 A·g^(-1)/0-4 V,which is superior to KNCMF-3#//AC LICs,KNCMF-3#@rGO//AC LICs,KNCMF-3#//AC+LFP+G LIC/Bs.In all,the novel Li-ion supercapattery idea adds a promising per-spective to develop advanced energy storage devices.展开更多
基金supported by grants from the National Key R&D Program of China (2021ZD0113200)the National Natural Sci-ence Foundation of China (81900526)
文摘Background: Early identification of patients with high mortality risk is critical for optimizing the clinical management of drug-induced liver injury(DILI). We aimed to develop and validate a new prognostic model to predict death within 6 months in DILI patients. Methods: This multicenter study retrospectively reviewed the medical records of DILI patients admitted to three hospitals. A DILI mortality predictive score was developed using multivariate logistic regression and was validated with area under the receiver operating characteristic curve(AUC). A high-mortality-risk subgroup was identified according to the score. Results: Three independent DILI cohorts, including one derivation cohort( n = 741) and two validation cohorts( n = 650, n = 617) were recruited. The DILI mortality predictive(DMP) score was calculated using parameters at disease onset as follows: 1.913 × international normalized ratio + 0.060 × total bilirubin(mg/d L) + 0.439 × aspartate aminotransferase/alanine aminotransferase – 1.579 × albumin(g/d L) –0.006 × platelet count(109/L) + 9.662. The predictive performance for 6-month mortality of DMP score was desirable, with an AUC of 0.941(95% CI: 0.922-0.957), 0.931(0.908-0.949) and 0.960(0.942-0.974) in the derivation, validation cohorts 1 and 2, respectively. DILI patients with a DMP score ≥ 8.5 were stratified into high-risk group, whose mortality rates were 23-, 36-, and 45-fold higher than those of other patients in the three cohorts. Conclusions: The novel model based on common laboratory findings can accurately predict mortality within 6 months in DILI patients, which should serve as an effective guidance for management of DILI in clinical practice.
文摘The fame of regeneration has been attributed to the liver ever since the era of Greek mythology,in which Prometheus’liver could grow back overnight against the daily predation of Zeus’eagle.Hepatectomy is the very basis of liver surgery including liver transplantation,and post-hepatectomy liver regeneration remains the center of interest for both clinicians and scientists.Novel tools for structural and functional assessment of liver regeneration have been constantly developed and validated,laying the groundwork for clinical management and scientific analysis(1).
基金financially supported by the National Natural Science Foundation of China (No. 22078279)
文摘An innovative K+vacant ternary perovskite fluoride(K_(0.89)Ni_(0.02)Co_(0.03)Mn_(0.95)F_(3.0),KNCMF-3#)anode was designed for advanced Li-ion supercapattery(i.e.,Li-ion capacitors/batteries,LIC/Bs).Owing to the conversion/insertion dual mechanisms and fast pseudocapacitive con-trol dynamics,the KNCMF-3#electrode exhibits superior electrochemical performance,especially the excellent cycle performance(467%(229 mAh·g^(-1))/1000 cycles/2 A·g^(-1)).Moreover,the hybrid KNCMF-3#/reduced gra-phene oxide(rGO)electrode can further increase the electrochemical performance(217-97 mAh·g^(-1)/0.1-3.2 A·g^(-1),150%(197 mAh·g^(-1))/1000 cycles/2 A·g^(-1)).Also,a novel capacitor/battery cathode,activated carbon(AC)+LiFePO_(4)+graphene(AC+LFP+G),exhibits impres-sive performance(128-82 mAh·g^(-1)/0.1-3.2 A·g^(-1),84%/1000 cycles/2 A·g^(-1)).By the synergistic optimization of anode and cathode,the Li-ion supercapattery KNCMF-3#@rGO//AC+LFP+G demonstrates remarkable per-formance,for example,111.9-23.8 Wh·kg^(-1)/0.4-8.0 kW·kg^(-1)/82%/2000 cycles/5 A·g^(-1)/0-4 V,which is superior to KNCMF-3#//AC LICs,KNCMF-3#@rGO//AC LICs,KNCMF-3#//AC+LFP+G LIC/Bs.In all,the novel Li-ion supercapattery idea adds a promising per-spective to develop advanced energy storage devices.
